CARDIFF ONCOLOGY, INC. Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
CARDIFF ONCOLOGY, INC. (CRDF) reported Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal of -$52.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-27.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal · last filed 2020-02-27
- CARDIFF ONCOLOGY, INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2018-12-31 was -$104.00K.
- CARDIFF ONCOLOGY, INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2018-09-30 was -$4.00K.
- CARDIFF ONCOLOGY, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2018 was -$52.00K.
| Period end | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 3 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 6 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 9 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$108.00K derived: sum of 2 quarters · filed 2020-02-27 | -$52.00K 10-K · filed 2020-02-27 | |
| 2018-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $52.00K 10-Q · filed 2018-11-07 | ||
| 2018-06-30 | $56.00K 10-Q · filed 2018-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |